adorable baby smiling with joy

Peds Calc

Pediatric Reference

Cefdinir Side EffectsComprehensive Pediatric Safety Guide

Cefdinir is generally well-tolerated in children, with most side effects being mild and self-limited. Gastrointestinal symptoms are most common, affecting approximately 8-15% of pediatric patients, with diarrhea being more frequent in children under 2 years. The distinctive red stool discoloration from iron interaction is benign but may alarm parents. Serious adverse events like pseudomembranous colitis are rare but require immediate attention.

4 Categories
14 Clinical Sources
Evidence-Based
Back to Cefdinir Overview

Essential Information

1

Diarrhea and Gastrointestinal Upset

The most common side effect, affecting 8% of pediatric patients overall, with higher rates (15%) in adults and up to 17% in children ≤2 years. Usually mild and self-limited, resolving without intervention. Management includes maintaining hydration and considering probiotics (Lactobacillus rhamnosus GG or Saccharomyces boulardii at 5-40 billion CFU/day) if approved by provider. Monitoring: Persistent or severe diarrhea may indicate antibiotic-associated colitis (including C. difficile infection) and should be evaluated promptly, especially if bloody or with fever.

2

Red Stool Discoloration

A distinctive but benign effect occurring when cefdinir interacts with iron in the GI tract, leading to reddish or rust-colored stools within 24-48 hours. This alarming appearance is not harmful and does not indicate bleeding or infection. Common in children taking iron-fortified formulas or supplements. Management: Reassure caregivers this is normal; separate iron supplements by 2 hours from cefdinir doses. Monitoring: Distinguish from actual blood in stool by noting the characteristic rust color and timing with iron intake.

3

Skin Rash

Non-specific rash, usually maculopapular and non-itchy, occurring more frequently in children under 2 years than older children and adults in clinical trials. While not always indicating true allergy, any rash warrants provider evaluation. Management: Continue medication if mild and child is otherwise well, but provider should assess. Use antihistamines or topical steroids per provider recommendation. Monitoring: Stop drug and seek immediate care for urticaria (hives), facial swelling, or signs of serious allergic reactions like difficulty breathing.

4

Drug Interactions Affecting Absorption

Cefdinir absorption is significantly reduced by antacids containing aluminum or magnesium, and iron supplements, potentially leading to treatment failure. Probenecid can increase cefdinir levels and toxicity risk. Management: Separate antacids and iron products by 2 hours before or after cefdinir. Iron-fortified infant formulas are acceptable. Avoid probenecid during treatment. Monitoring: Watch for reduced effectiveness if interaction occurs, and ensure proper spacing of medications.

5

Serious Adverse Events

Rare but important complications include Stevens-Johnson syndrome, toxic epidermal necrolysis, and C. difficile-associated diarrhea (CDAD). Some parents report behavioral changes in toddlers, though specific incidence data is limited. Management: Discontinue immediately for severe skin reactions or signs of CDAD. Seek emergency care for widespread rash with fever or severe, persistent diarrhea with cramping. Monitoring: Watch for severe skin reactions, bloody diarrhea, fever, or unusual behavioral changes during treatment.

Clinical Overview

Cefdinir adverse effects mirror those of other cephalosporins, with diarrhea (8-17% depending on age), skin rash (more common in children <2 years), and nausea being most frequent. Distinctive red stool discoloration occurs with iron co-administration. Serious events include pseudomembranous colitis, severe skin reactions (Stevens-Johnson syndrome), and potential nephrotoxicity when combined with aminoglycosides.

Side Effect Categories

4 Systems

Gastrointestinal

3 documented effects

Total Sources: 6

Diarrhea

Incidence: ≈8% pediatric overall; 15% adults/adolescents; 17% in children ≤2 years
Onset: Within 24-48 hours of first dose
Mild (Grade 1)
2 sources
Duration

1-3 days after discontinuation

Management

Maintain hydration; consider probiotics (L. rhamnosus GG or S. boulardii 5-40 billion CFU/day); avoid anti-diarrheal medications

Monitoring Guidelines

Report if severe, bloody, persistent >3 days, or associated with fever/cramping

2 clinical sources• PubMed • Clinical Guidelines • FDA

Red Stool Discoloration

Incidence: Common when taken with iron supplements or iron-fortified formulas
Onset: Within 24-48 hours of concurrent iron intake
Benign (no clinical significance)
2 sources
Duration

Resolves after iron separation or drug discontinuation

Management

Reassure caregivers; separate iron supplements by 2 hours; iron-fortified formulas are acceptable

Monitoring Guidelines

Distinguish from actual blood in stool; characteristic rust color with iron timing

2 clinical sources• PubMed • Clinical Guidelines • FDA

Nausea and Vomiting

Incidence: Common; exact pediatric percentage not specified
Onset: Within hours of administration
Mild (Grade 1)
2 sources
Duration

Self-limited; resolves between doses

Management

Give with food if stomach upset occurs; ensure adequate hydration

Monitoring Guidelines

Report persistent vomiting preventing oral intake or signs of dehydration

2 clinical sources• PubMed • Clinical Guidelines • FDA

Skin

2 documented effects

Total Sources: 4

Maculopapular Rash

Incidence: More frequent in children <2 years than older children and adults in clinical trials
Onset: Days 3-7 of therapy
Mild-moderate (Grade 1-2)
2 sources
Duration

Up to 1 week after discontinuation

Management

Continue if mild and child well; antihistamines or topical steroids per provider guidance

Monitoring Guidelines

Seek immediate care for hives, facial swelling, or breathing difficulty

2 clinical sources• PubMed • Clinical Guidelines • FDA

Stevens-Johnson Syndrome/TEN

Incidence: Rare (<0.1%)
Onset: Variable; usually within first few weeks
Severe to Life-threatening (Grade 3-4)
2 sources
Duration

Can be prolonged; requires intensive care

Management

Discontinue immediately; emergency medical care; supportive treatment

Monitoring Guidelines

Watch for widespread rash with fever, blistering, or mucosal involvement

2 clinical sources• PubMed • Clinical Guidelines • FDA

Behavioral/Neurologic

1 documented effect

Total Sources: 2

Behavioral Changes in Toddlers

Incidence: Anecdotal reports; specific incidence unknown
Onset: Variable during treatment course
Mild-moderate (Grade 1-2)
2 sources
Duration

Usually resolves after discontinuation

Management

Monitor closely; consider alternative antibiotic if severe; supportive care

Monitoring Guidelines

Report unusual hyperactivity, irritability, sleep disturbances, or mood changes

2 clinical sources• PubMed • Clinical Guidelines • FDA

Renal/Nephrotoxic

1 documented effect

Total Sources: 2

Nephrotoxicity with Aminoglycosides

Incidence: Increased risk when combined; specific percentage not established
Onset: With concurrent use or shortly after
Moderate to Severe (Grade 2-3)
2 sources
Duration

Variable; may require dose adjustment or discontinuation

Management

Monitor renal function; adjust doses based on creatinine clearance; avoid combination when possible

Monitoring Guidelines

Regular serum creatinine and BUN monitoring; watch for decreased urine output

2 clinical sources• PubMed • Clinical Guidelines • FDA

Risk Factors

Age under 2 years (higher risk of diarrhea and rash)

Sources: 2 references

Concurrent iron supplementation (red stool discoloration)

Sources: 2 references

History of cephalosporin or penicillin allergy

Sources: 2 references

Concurrent aminoglycoside therapy (nephrotoxicity risk)

Sources: 2 references

Previous C. difficile infection or recent antibiotic use

Sources: 2 references

Prevention & Safety Tips

Use probiotics (L. rhamnosus GG or S. boulardii 5-40 billion CFU/day) to prevent antibiotic-associated diarrhea (NNT=6-9); separate iron supplements and antacids by 2 hours; maintain hydration; complete full course even if symptoms improve; take with food if GI upset occurs

When to Contact Your Pediatrician

Important

📞 Call your pediatrician immediately if you notice any of these symptoms:

Severe, bloody, or persistent diarrhea with fever or cramping

Widespread rash with fever, blistering, or mouth/eye involvement

Signs of allergic reaction (hives, facial swelling, difficulty breathing)

Severe dehydration from vomiting or diarrhea

Unusual behavioral changes or severe irritability in toddlers

Signs of kidney problems (decreased urination, swelling, fatigue)

Comparison with Amoxicillin

EffectCefdinirAmoxicillin
Diarrhea8-17% (age-dependent)≈10%
Red stool discolorationCommon with ironDoes not occur
Drug interactionsSignificant with iron/antacidsMinimal

Important Drug Interactions

!

Antacids (aluminum/magnesium)

Reduced cefdinir absorption; separate by 2 hours before or after

!

Iron supplements

Reduced absorption and red stool discoloration; separate by 2 hours

!

Probenecid

Increased cefdinir levels and toxicity risk; monitor closely

!

Aminoglycosides

Increased nephrotoxicity risk; monitor renal function closely

!

Live bacterial vaccines (BCG, cholera)

Reduced vaccine effectiveness; wait until antibiotic course complete

Parent Communication Guide

Age-Appropriate Explanations

Infants (0-12 months)

Cefdinir is safe for babies over 6 months old. If your baby takes iron-fortified formula, you may notice rust-colored stools - this is completely normal and harmless. Watch for unusual fussiness, decreased feeding, or rash.

Toddlers (1-3 years)

Your toddler's medicine might make their poop look reddish like rust if they take vitamins with iron. This isn't scary - it's just the medicine mixing with iron. Some toddlers may be a bit fussier or have looser stools while taking this medicine.

Children (4-12 years)

Cefdinir is an antibiotic that helps fight infections. If you take vitamins with iron, your poop might look red or rust-colored - this is normal and not dangerous. Tell your parents if you feel sick, get a rash, or have bad stomach aches.

Adolescents (13+ years)

Cefdinir may cause red-colored stools if taken with iron supplements or multivitamins containing iron. This is a harmless interaction, not bleeding. Complete the full course even if you feel better, and report severe diarrhea, rash, or allergic reactions.

Common Parent Concerns

Q: My child's stool is red - should I stop the medication?

A: Red stools from cefdinir + iron interaction are completely harmless. This is not blood and doesn't require stopping the medication. Continue the full antibiotic course as prescribed.

When to validate: Contact us if stools are truly bloody (bright red with visible blood), black and tarry, or if your child has severe abdominal pain or signs of illness.

Q: Can my child with a penicillin allergy safely take cefdinir?

A: Yes, cefdinir is safe for most children with penicillin allergies (less than 1% cross-reaction risk). The American Academy of Pediatrics recommends it for penicillin-allergic children.

When to validate: Do not use if the penicillin reaction was severe (breathing problems, facial swelling, emergency treatment). Contact us immediately if any new allergic symptoms develop.

Q: Should I separate iron supplements from cefdinir?

A: You may separate iron supplements by 2 hours to reduce red stool discoloration and slightly improve absorption, but it's not medically necessary. Continue iron-fortified formula normally.

When to validate: Contact us if you have concerns about medication timing or if your child isn't improving as expected.

Q: My child seems more irritable on cefdinir - is this normal?

A: Some toddlers experience mild behavioral changes (irritability, sleep disruption) while on antibiotics. This is usually temporary and resolves after completing treatment.

When to validate: Contact us if behavioral changes are severe, persistent beyond treatment, or if you notice other concerning symptoms.

Clinical Decision Support

Severity Assessment Framework

Evidence-based clinical assessment framework for cefdinir adverse effects with specific focus on unique characteristics

Treatment Decision Guidelines

Immediate Discontinuation

  • Type I allergic reactions (anaphylaxis, angioedema, bronchospasm)
  • Severe skin reactions (Stevens-Johnson syndrome, TEN)
  • C. difficile-associated diarrhea (bloody diarrhea with fever)
  • Signs of severe toxicity or organ dysfunction

Consider Alternatives

  • Moderate allergic reactions in high-risk patients
  • Persistent moderate GI side effects affecting quality of life
  • Inadequate therapeutic response with proper dosing
  • Significant drug interactions affecting efficacy

Dose Modification

    Frequently Asked Questions

    Parent and clinician concerns about Cefdinir